What question did this study set out to answer?

To evaluate the efficacy of trans sodium crocetinate and crocetin in improving myocardial reperfusion in STEMI patients.

February 8, 20260 citations

Evaluation of the effect of trans sodium crocetinate and crocetin on reperfusion injury in acute myocardial infarction with ST-segment elevation: A double-blind, randomized, placebo-controlled clinical trial.

GEGhazaleh ElahabadiMashhad University of Medical Sciences AGArash GholoobiMashhad University of Medical Sciences JRJavad RamezaniMashhad University of Medical Sciences

Key Points

To evaluate the efficacy of trans sodium crocetinate and crocetin in improving myocardial reperfusion in STEMI patients.
Double-blind, randomized, placebo-controlled trial
Administered TSC injection and crocetin tablets post-PPCI
Measured ST-segment resolution and cardiac remodeling outcomes
Improved myocardial reperfusion indicated by enhanced ST-segment resolution
No observed benefits in cardiac remodeling or CTIMIFC
Supportive safety profile for TSC and crocetin, warranting further research

Abstract

TSC (0.5 mg/kg injection pre-PPCI + 7.5 mg crocetin tablets for 3 days) administration improved myocardial reperfusion, as evidenced by enhanced ST-segment resolution, suggesting reduced reperfusion injury in STEMI patients post-PPCI. While no benefits were observed in CTIMIFC or cardiac remodeling, the safety profile and primary outcome results support further investigation. Larger trials are needed to confirm efficacy and assess long-term clinical impacts.

AI에게 질문

Bookmark

View Full Paper